Common Contracts
4 similar Additional Issuance Agreement contracts by Rennova Health, Inc.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • June 28th, 2018 • Rennova Health, Inc. • Services-testing laboratories
This Additional Issuance Agreement (this “Agreement”), dated as of June 27, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and between Rennova Health, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture due September 19, 2019 (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • May 21st, 2018 • Rennova Health, Inc. • Services-testing laboratories
This Additional Issuance Agreement (this “Agreement”), dated as of May 20, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and between Rennova Health, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture due September 19, 2019 (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • May 14th, 2018 • Rennova Health, Inc. • Services-testing laboratories
This Additional Issuance Agreement (this “Agreement”), dated as of May 13, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and between Rennova Health, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture due September 19, 2019 (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • March 6th, 2018 • Rennova Health, Inc. • Services-testing laboratories
This Additional Issuance Agreement (this “Agreement”), dated as of March 5, 2018, is made pursuant to that certain Securities Purchase Agreement, dated as of August 31, 2017 (the “Purchase Agreement”), as amended, by and between Rennova Health, Inc. (the “Company”) and the purchaser signatory hereto (the “Purchaser”) for the purchase of the Company’s Senior Secured Original Issue Discount Convertible Debenture due September 19, 2019 (the “Additional Debenture”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
